Gateway 2011:Natoli Engineering Company, Inc - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011:Natoli Engineering Company, Inc



Your online Gateway to Natoli Engineering Company, Inc. in 2011

28 Research Park Circle
St. Charles, MO 63304
636-926-8900  
Fax: 636-926-8910
www.natoli.com

About Natoli Engineering Company, Inc.

Natoli Tooling

Natoli has provided top quality tablet compression tooling for over 35 years and have grown to offer an extensive line of products and services to assist all stages of the tablet production process. No other company in the industry offers a more complete range of products and services, and their commitment to innovation and excellence has earned them an international reputation for high quality and reliability.

 

Natoli offers world-renowned tablet compression tooling, tablet presses, press refurbishing services, replacement parts and turrets, punch inspection systems and software, Light Induced Fluorescence (LIF) Sensor, technical training courses, and an all-new Tablet Compression Accessories Catalog.

Light Induced Fluorescence (LIF) Sensor

Natoli Engineering Company, Inc. invites you to join us at Interphex 2011. We will be showcasing our newest product, the Light Induced Fluorescence (LIF) Sensor. As a valuable new analytical process technology, the LIF Sensor was designed for process cleaning validation, liquid applications and blend uniformity endpoint monitoring. Stop by our booth to see a product demonstration and speak with one of our experts about what the LIF Sensor can do for you!

 

For more information:

info@natoli.com  

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here